| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90834 |
Psychotherapy, 45 minutes with patient |
46,337 |
21,551 |
$3.90M |
| S9485 |
Crisis intervention mental health services, per diem |
984 |
764 |
$680K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,864 |
5,712 |
$556K |
| 96133 |
|
1,133 |
1,131 |
$522K |
| 90791 |
Psychiatric diagnostic evaluation |
3,688 |
3,568 |
$512K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,676 |
2,553 |
$433K |
| 96137 |
|
1,085 |
1,077 |
$431K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,128 |
2,057 |
$328K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,215 |
5,057 |
$318K |
| 96118 |
|
254 |
254 |
$244K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
439 |
415 |
$186K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
2,085 |
1,283 |
$183K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,768 |
1,090 |
$182K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
1,636 |
1,635 |
$176K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,034 |
990 |
$174K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
1,277 |
1,130 |
$123K |
| 96132 |
|
1,145 |
1,142 |
$122K |
| 99215 |
Prolong outpt/office vis |
708 |
696 |
$90K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,728 |
1,292 |
$73K |
| 96136 |
|
1,086 |
1,081 |
$53K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
241 |
239 |
$40K |
| 90887 |
|
946 |
621 |
$39K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
306 |
191 |
$39K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,013 |
399 |
$34K |
| 99402 |
|
409 |
407 |
$33K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
159 |
155 |
$33K |
| 96139 |
|
99 |
99 |
$28K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
587 |
518 |
$27K |
| 87631 |
|
245 |
237 |
$27K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
965 |
897 |
$22K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
109 |
99 |
$15K |
| 90882 |
|
335 |
235 |
$14K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,356 |
2,886 |
$14K |
| 70450 |
Computed tomography, head or brain; without contrast material |
234 |
229 |
$13K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
87 |
86 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,218 |
2,657 |
$10K |
| 86140 |
|
495 |
472 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,766 |
1,680 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,513 |
1,492 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
185 |
175 |
$8K |
| 86480 |
|
134 |
134 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,157 |
1,151 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
566 |
564 |
$6K |
| 80053 |
Comprehensive metabolic panel |
1,648 |
1,601 |
$6K |
| 86618 |
|
83 |
81 |
$5K |
| G0378 |
Hospital observation service, per hour |
192 |
142 |
$5K |
| 87070 |
|
588 |
584 |
$5K |
| 83516 |
|
149 |
149 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
1,161 |
1,121 |
$4K |
| 82728 |
|
382 |
379 |
$4K |
| 84439 |
|
636 |
629 |
$4K |
| 96138 |
|
125 |
125 |
$4K |
| 80076 |
|
1,055 |
1,007 |
$4K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
27 |
27 |
$3K |
| 87077 |
|
654 |
630 |
$3K |
| 86664 |
|
60 |
59 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
498 |
498 |
$3K |
| 87186 |
|
742 |
701 |
$3K |
| 86665 |
|
60 |
59 |
$3K |
| 80061 |
Lipid panel |
1,431 |
1,426 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
16 |
14 |
$2K |
| 81025 |
|
332 |
326 |
$2K |
| 83690 |
|
325 |
311 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
152 |
151 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
66 |
65 |
$2K |
| J3490 |
Unclassified drugs |
45 |
37 |
$2K |
| 84484 |
|
190 |
169 |
$2K |
| 83550 |
|
233 |
232 |
$2K |
| 82784 |
|
139 |
139 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
42 |
41 |
$2K |
| 83655 |
|
106 |
106 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
561 |
533 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
27 |
25 |
$1K |
| 77080 |
|
189 |
189 |
$1K |
| 83540 |
|
277 |
276 |
$1K |
| 83735 |
|
703 |
579 |
$1K |
| 80050 |
General health panel |
74 |
74 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
41 |
40 |
$1K |
| 83880 |
|
114 |
100 |
$1K |
| 85652 |
|
428 |
414 |
$1K |
| 81001 |
|
855 |
817 |
$901.65 |
| 82150 |
|
57 |
57 |
$830.34 |
| 86803 |
|
44 |
44 |
$801.74 |
| 82607 |
|
379 |
375 |
$768.26 |
| 85027 |
|
1,101 |
1,042 |
$754.01 |
| 87040 |
|
60 |
59 |
$719.41 |
| 86003 |
|
14 |
14 |
$713.50 |
| 81002 |
|
256 |
253 |
$657.68 |
| 86039 |
|
13 |
13 |
$617.88 |
| 84153 |
|
308 |
305 |
$616.48 |
| 87205 |
|
179 |
177 |
$576.83 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
154 |
154 |
$549.30 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
751 |
672 |
$532.68 |
| 71045 |
Radiologic examination, chest; single view |
135 |
132 |
$448.99 |
| 82248 |
|
52 |
39 |
$439.01 |
| 84460 |
|
102 |
95 |
$423.72 |
| 84702 |
|
25 |
25 |
$375.07 |
| 83970 |
|
107 |
106 |
$371.55 |
| 36415 |
Collection of venous blood by venipuncture |
3,814 |
2,855 |
$371.46 |
| 85610 |
|
1,686 |
906 |
$331.75 |
| 82043 |
|
528 |
524 |
$320.54 |
| 84450 |
|
66 |
60 |
$287.60 |
| 84436 |
|
31 |
31 |
$286.08 |
| 87046 |
|
32 |
30 |
$240.80 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
158 |
78 |
$236.68 |
| 73610 |
|
48 |
48 |
$226.83 |
| 87045 |
|
31 |
30 |
$223.08 |
| 81003 |
|
172 |
165 |
$214.99 |
| 84100 |
|
145 |
133 |
$162.50 |
| 86900 |
|
13 |
13 |
$156.43 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
27 |
25 |
$140.49 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12 |
12 |
$134.53 |
| 86038 |
|
18 |
18 |
$132.24 |
| 83605 |
|
13 |
12 |
$126.75 |
| 86780 |
|
13 |
13 |
$120.70 |
| 87081 |
|
25 |
25 |
$119.02 |
| 82565 |
|
67 |
62 |
$105.99 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
184 |
168 |
$105.00 |
| 84703 |
|
13 |
13 |
$89.18 |
| 85045 |
|
31 |
29 |
$88.16 |
| 73630 |
|
24 |
24 |
$75.61 |
| 86850 |
|
12 |
12 |
$64.98 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
28 |
26 |
$57.70 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
237 |
226 |
$45.94 |
| 87076 |
|
72 |
67 |
$34.80 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
350 |
212 |
$29.40 |
| 86901 |
|
13 |
13 |
$27.30 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
187 |
182 |
$0.00 |
| 73130 |
|
14 |
13 |
$0.00 |
| 82948 |
|
16 |
13 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
116 |
58 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
206 |
187 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
52 |
49 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
36 |
36 |
$0.00 |
| 82962 |
|
297 |
214 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
166 |
107 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
99 |
87 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
108 |
96 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
15 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
87 |
78 |
$0.00 |
| 82746 |
|
13 |
13 |
$0.00 |
| 80069 |
|
13 |
12 |
$0.00 |